Post by Anupam Agarwal, MD, MPH
Healthcare Investor | AI & Medicine | Capital Allocation & Governance | MD, MPH (Harvard)
Hosting Tyler Shultz at the Harvard Healthcare series was a remarkable experience that highlighted the importance of ethics in innovation. His firsthand account of the Theranos saga resonated deeply with the audience, revealing not just the complexities of corporate malfeasance but also the profound courage it takes to stand up for truth. Inspiring Narrative: Tyler’s story serves as a powerful reminder of the impact one individual can have in the face of overwhelming odds. His determination to expose the truth about Theranos resonated with over 100 attendees, fostering a sense of community and shared values. Engaging Discussion: With over 100 participants, the atmosphere was electric. Attendees engaged in a lively Q&A, reflecting a genuine interest in the ethical implications of innovation and the personal cost of truth-telling. This interaction underscored the need for transparency in business practices. Overall, the event not only informed but also empowered attendees to champion ethical practices in their own fields.